Survival protein clue to immune cell recovery following chemotherapy

March 2, 2018, Walter and Eliza Hall Institute of Medical Research
Survival protein clue to immune cell recovery following chemotherapy
Dr Reema Jain (left) and Associate Professor Daniel Gray have identified a protein essential for the survival of specialised thymus cells . Credit: Walter and Eliza Hall Institute of Medical Research

One well-known side effect of conventional cancer treatments, such as chemotherapy, is the severe damage that it causes to the immune system.

Chemotherapy decimates the , an immune organ responsible for training T , a type of white blood cell that protects us against infection and cancer. This damage leaves patients extremely susceptible to infection.

Institute scientists have identified a protein that is essential for the survival of a specialised kind of thymus cell called thymic epithelial cells (TECs). TECs control the thymus and its ability to regenerate after damage, and are integral to the training and development of T cells.

They hope the discovery will lead to future treatments that protect or regenerate the thymus after cancer treatment.

Stem cell transplant side effects

The research was led by Associate Professor Daniel Gray and Dr. Reema Jain, with colleagues at the Institute, and was published in the journal Blood.

Associate Professor Gray said a desire to improve patients' immune systems following chemotherapy had been the motivation for their research into the thymus.

"The treatment that some cancer patients receive in the lead up to a bone marrow or kills their cancer cells, but also causes a lot of collateral damage to the immune system and their thymus," Associate Professor Gray said.

"Patients are then given a drug – called G-CSF – that replenishes some types of that fight infection. However there is no drug to replenish their T cells, and it takes many years for their T cells to recover, and for some people this never happens."

Years without an active thymus and T cells leave people susceptible to opportunistic infections.

"These individuals often succumb to viral infections because T-cell recovery is too slow. We are hoping to uncover a way of replenishing these T cells by protecting or regenerating the thymus, which is essential for T cell repopulation," said Associate Professor Gray.

TECs are the key

Thymic epithelial cells – TECs – are believed to play a central role in maintenance and recovery of the thymus.

TECs were essential for the immune system because they teach and control the development of T cells, Dr. Jain said.

"These cells have, until now, been a bit of a 'black box' because there are so few of them and they are very hard to study for technical reasons," she said.

Having overcome these technical difficulties, the research team was able to uncover the critical molecules that controlled the life and death of TECs.

"We found that an important pro-survival protein, MCL-1, was essential for the maintenance of TECs. If we removed MCL-1 from these cells, not only did the TECs die, the whole thymus basically disappeared. Without MCL-1 the thymus collapses and can no longer produce T cells," Dr. Jain said.

Regenerating the thymus

Associate Professor Gray said increasing the levels of MCL-1 in TECs to increase their survival could be one way of regenerating the thymus.

"By understanding the key molecules that drive the survival of TECs we could develop treatments that protect the thymus during chemotherapy, or promote its regeneration after treatment," he said.

"Essentially we are looking for the 'thymus G-CSF' – a drug that you could give to patients that would protect or regenerate their thymus, and therefore their T cells, after they have been damaged with treatment."

Explore further: Can we turn back the clock on an aging thymus?

More information: Reema Jain et al. A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice, Blood (2017). DOI: 10.1182/blood-2017-03-771576

Related Stories

Can we turn back the clock on an aging thymus?

December 22, 2017
As we age our thymus shrinks and is replaced by fatty tissue, losing its essential ability to grow and develop T cells and leaving us susceptible to infections, immune disorders and cancers.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

Disease risk after pediatric heart surgery

February 22, 2018
Infections and autoimmune diseases are more common among people who have undergone heart surgery as children and had their thymus removed at the same time, which is often done to get access to the heart. This is evident in ...

Researchers identify possible pathway to reboot immune system after bone-marrow transplants

August 25, 2016
New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant ...

New quality control revealed in immune T cell development

November 18, 2016
The research into T cell development within an organ called the thymus revealed for the first time that a protein complex called LUBAC enables 'quality control' of the cells before they are released into the bloodstream.

Recommended for you

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Mumps resurgence likely due to waning vaccine-derived immunity

March 21, 2018
A resurgence of mumps in the U.S. among vaccinated young adults appears to be due to waning of vaccine-induced immunity, according to a new analysis from Harvard T.H. Chan School of Public Health. Researchers found that vaccine-derived ...

How allergens trigger asthma attacks

March 19, 2018
A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology have identified a protein that acts like a sensor detecting allergens in the respiratory tract that are responsible for asthma ...

Quintupling inhaler medication may not prevent asthma attacks in children

March 19, 2018
Children with mild to moderate asthma do not benefit from a common practice of increasing their inhaled steroids at the first signs of an asthma exacerbation, according to clinical trial results published in The New England ...

Single steroid-bronchodilator treatment for control and rescue improves persistent asthma

March 19, 2018
When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during sudden asthma attacks is ...

Obesity and health problems: New research on a safeguard mechanism

March 16, 2018
Obesity and its negative impacts on health - including metabolic syndrome, type-2 diabetes mellitus and cardiovascular complications - are a global pandemic (Taubes, 2009). The worldwide incidence of obesity has more than ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.